Production processClosed Production

Products 31 to 40 of 174

bioCement by bioMason
Biotech components: Bacteria
Business models: B2B + B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial + Government
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/10/08 14:47 (2 years ago)
Known funding amount: 2,800,000 USD
Funding types: Foundation + Government + University + Venture Capital
Industry: Industrial
Market status: Under Development
Organization type(s): Private Company
Product categories: Construction
Production process: Closed Production
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: Gene Editing
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Research
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/09/28 16:57 (2 years ago)
Known funding amount: 250,000 USD
Funding types: Private Funding
Industry: Health
Market status: Under Development
Organization type(s): Private Company
Product categories: Medical Treatment
Production process: Closed Production
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Input
BioIsoprene by DuPont
Biotech components: Plant
Business models: B2B
Country of production: USA
Country of distribution: N/A
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/08/30 11:49 (2 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Industrial
Market status: Under Development
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: DWDP (NYSE)
Value chain stage: Input
Biotech components: Bacteria
Business models: B2C
Country of production: France
Country of distribution: France
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/09/19 11:53 (2 years ago)
Known funding amount: N/A
Funding types: Private Funding
Industry: Industrial
Market status: Under Development
Organization type(s): Private Company
Product categories: Fuel and Energy
Production process: Closed Production
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: Microbe
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Research
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/08/30 11:49 (2 years ago)
Known funding amount: 3,498,401 USD
Funding types: Government
Industry: Science
Market status: Early Stage Concept
Organization type(s): University
Product categories: Research
Production process: Closed Production
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Platform
Biolon DDDA by Verdezyne
Biotech components: Plant
Business models: B2B
Country of production: Malaysia
Country of distribution: Europe
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/11/08 14:44 (2 years ago)
Known funding amount: 86,500,000 USD
Funding types: Venture Capital
Industry: Industrial
Market status: More information needed + No longer on the market
Organization type(s): Private Company
Product categories: Chemical
Production process: Closed Production
Source: Web search
Trading symbol: N/A
Value chain stage: Input
Biopolymer I6001 by Yield10 Bioscience + Metabolix
Biotech components: Bacteria + Plant
Business models: B2B
Country of production: USA
Country of distribution: USA + Europe
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/10/01 09:56 (2 years ago)
Known funding amount: 41,800,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: YTEN (NASDAQ)
Value chain stage: Input
Biopolymer I6003rp by Yield10 Bioscience + Metabolix
Biotech components: Bacteria + Plant
Business models: B2B
Country of production: USA
Country of distribution: USA + Europe
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/10/01 09:56 (2 years ago)
Known funding amount: 41,800,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: YTEN (NASDAQ)
Value chain stage: Input
Biopolymer Mvera B5010 (Mirel) by Yield10 Bioscience + Metabolix
Biotech components: Bacteria + Plant
Business models: B2B
Country of production: USA
Country of distribution: N/A
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/08/30 11:49 (2 years ago)
Known funding amount: 41,800,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: YTEN (NASDAQ)
Value chain stage: Input
Biopolymer Mvera B5011 (Mirel) by Yield10 Bioscience + Metabolix
Biotech components: Bacteria + Plant
Business models: B2B
Country of production: USA
Country of distribution: USA + Europe
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (2 years ago)
Date last modified: 2018/08/30 11:49 (2 years ago)
Known funding amount: 41,800,000 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Closed Production
Source: SynBio Database
Trading symbol: YTEN (NASDAQ)
Value chain stage: Input